Kamal Adawi, Chief Financial Officer at FATE THERAPEUTICS INC (FATE), sold 6,582 shares at $2.05 ($14K) on 2026-11-03, disclosed to the SEC on 2026-11-04.
Open-market sale of $14k FATE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| XGN | SELL | 2023-03-03 | $8K | — | Filing → |
| XGN | SELL | 2023-02-10 | $16K | — | Filing → |